The result is significantly lower costs, allowing Ligand to be highly profitable on what would normally be a revenue figure that's too small to lead to recurring profits for
traditional drug companies.
Not exact matches
They argue that many
companies stick with
traditional PBMs because
drug pricing is so impossible to untangle that customers have no way to verify how much they're saving, if anything.
«The intensifying battle for negotiating power and market share will lead
companies to do acquisitions across
traditional industry boundary lines,» said Erik Gordon, a professor at the Ross School of Business at the University of Michigan who studies the
drug industry.
The timeline to have a commercial product is much shorter than a
traditional biotech
company developing a new
drug.
«3D Signatures» timeline to have a commercial product is much shorter than a
traditional biotech
company developing a new
drug.»
Unlike a
traditional drug, every order needs to be placed through the
companies — and it's not clear whether they and FDA will support off - label use.
Beyond that, it was the institute that moved Roche into biotechnology and changed it from a
traditional, chemically oriented
drug company to a modern pharmaceutical
company.
The most important change occurring in the industry is a shift away from the
traditional «big pharma» model for
drug development, in which research and development are concentrated inside such
companies as Pfizer, Merck, and AstraZeneca.
Those were developed, in part, as a byproduct of previous alliances in which pharmaceutical
companies payed for rights to develop would - be
drugs discovered at Scripps, as well as through the more
traditional approach of licensing early - stage compounds to startup
companies that then raise money to develop them further.
Such trials are inevitably costly, and the
traditional strategy for
drug development suggests one means of undertaking these development expenses is for wellfunded
companies to lead the way, motivated by the potential return on investment to be gained from a successful proprietary therapy.
«
Traditional Treatments» means synthetic chemically altered hormones sold by the
drug companies.
A group of former editors of the Canadian Medical Association Journal (CMAJ) has launched today an open - source, peer - reviewed medical journal that hopes to avoid what they say are editorial biases in
traditional journals having to do with the important role research played by
drug and medical appliance
companies.
(In more recent times, psychology,
drugs, pornography — woman ownership — and consumerism substitute in part for
traditional patriarchal religion in keeping the labor force subdued and beholden to the
company store.)